Weekly doses may be fractionated into twice-weekly administrations (e.g., 1.25 mg biweekly) to support tolerability or administration preferences
Error 2: using the wrong concentration A patient has been using a 2.5 mg/mL vial and drawing 10 units (0.25 mg) weekly
A well-structured program provides clarity, measurable outcomes, and ongoing guidance throughout
While all states cover at least one Type 2 diabetes-indicated GLP-1, coverage for obesity-indicated options is less consistent
However, their therapeutic efficacy is significantly influenced by pharmacokinetic factors, including absorption, distribution, metabolism and excretion, which directly impact their bioavailability [99]
9 Globally, the market for GLP-1s reached $50 billion in 2024, with projections to more than double by 2030 10 and already millions of Americans are prescribed the treatment